|
||||||||||||||||||||||
|
|||||||||||||||||||||||
|
|
|||||||||||||||||||||||
|
 Reader
Comments
Year : 2022 | Volume: 11 | Issue Number: 2 ORIGINAL ARTICLEActive surveillance of adverse events following the first dose of COVID-19 vaccination – Oxford–AstraZeneca (Covishield) vaccine Varghese Sangeetha Merrin, John Grace Mary, George Geomcy, Jacob Linda, Paul Mammen, Sachu Arun, Samuel Johnson Abel K, Chandy George Mateethra
|
||||||||||
|
||||||
